Singapore Research Finds Treatment For Fatal Heart-Rhythm Disorder
This article was originally published in PharmAsia News
Executive Summary
Singapore researchers reported success in using ALLN, a calpain inhibitor, to reverse a potentially fatal heart-rhythm disorder, QT syndrome 2.